Aspartic Protease Inhibitors as Potential Anti-Candida albicans Drugs: Impacts on Fungal Biology, Virulence and Pathogenesis

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|18|16|2401-2419

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.18, Iss.16, 2011-06, pp. : 2401-2419

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Aspartic Protease Inhibitors: Effective Drugs against the Human Fungal Pathogen Candida albicans

By  

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 1, 2013-01 ,pp. : 155-162

Bentham Science Publishers

Access to resources Recommend Favorite

Imidazolium Ionic Liquids as Potential Anti-Candida Inhibitors: QSAR Modeling and Experimental Studies

By  

Current Drug Discovery Technologies, Vol. 13, Iss. 2, 2016-08 ,pp. : 109-119

Bentham Science Publishers

Access to resources Recommend Favorite

Synthetic and Natural Protease Inhibitors Provide Insights into Parasite Development, Virulence and Pathogenesis

By  

Current Medicinal Chemistry, Vol. 20, Iss. 25, 2013-08 ,pp. : 3078-3102

Bentham Science Publishers

Access to resources Recommend Favorite

Action of Anti-HIV Drugs and Resistance: Reverse Transcriptase Inhibitors and Protease Inhibitors

By  

Current Pharmaceutical Design, Vol. 10, Iss. 32, 2004-12 ,pp. : 4039-4053

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of the Plasmodium Falciparum Parasite Aspartic Protease Plasmepsin II As Potential Antimalarial Agents

By  

Current Medicinal Chemistry, Vol. 10, Iss. 11, 2003-06 ,pp. : 883-907

Bentham Science Publishers

Access to resources Recommend Favorite